UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment

Journal of nanobiotechnology, 2022-10, Vol.20 (1), p.446-446, Article 446

2022

Volltextzugriff (PDF)

Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer

PloS one, 2018-04, Vol.13 (4), p.e0196017-e0196017

2018

Volltextzugriff (PDF)

A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells

BMC cancer, 2020-12, Vol.20 (1), p.1214-1214, Article 1214

2020

Volltextzugriff (PDF)

Glypican‐1 as a target for fluorescence molecular imaging of bladder cancer

International journal of urology, 2021-12, Vol.28 (12), p.1290-1297

2021

Volltextzugriff (PDF)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211022918

2021

Volltextzugriff (PDF)

Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)

EJNMMI research, 2020-05, Vol.10 (1), p.46-46, Article 46

2020

Volltextzugriff (PDF)

Enabling Sensitive Phenotypic Profiling of Cancer-Derived Small Extracellular Vesicles Using Surface-Enhanced Raman Spectroscopy Nanotags

ACS sensors, 2020-03, Vol.5 (3), p.764-771

2020

Volltextzugriff (PDF)

The Role of Glypican-1 in the Tumour Microenvironment

Advances in experimental medicine and biology, 2020, Vol.1245, p.163-176

2020

Volltextzugriff (PDF)

Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican‑1 Targeting Immuno-PET Agents in Glioblastoma

Molecular pharmaceutics, 2023-03, Vol.20 (3), p.1549-1563

2023

Volltextzugriff (PDF)

PI3-kinase-dependent activation of apoptotic machinery occurs on commitment of epidermal keratinocytes to terminal differentiation

Cell research, 2009-03, Vol.19 (3), p.328-339

2009

Volltextzugriff (PDF)

Pharmacokinetics and Biodistribution of 89 Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma

Molecular pharmaceutics, 2023-03, Vol.20 (3), p.1549-1563

2023

Volltextzugriff (PDF)

Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study

Analytical methods, 2022-06, Vol.14 (23), p.2255-2265

2022

Volltextzugriff (PDF)

Upconversion nanoparticle‐assisted single‐molecule assay for detecting circulating antigens of aggressive prostate cancer

Cytometry. Part A, 2022-05, Vol.101 (5), p.400-410

2022

Volltextzugriff (PDF)

Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer

Urologic oncology, 2023-11, Vol.41 (11), p.454.e9-454.e16

2023

Volltextzugriff (PDF)

Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab ® -IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery

Cancers, 2020-04, Vol.12 (4), p.984

2020

Volltextzugriff (PDF)

Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization

Journal of Cancer, 2016-01, Vol.7 (8), p.1002-1009

2016

Volltextzugriff (PDF)

The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors

Photodiagnosis and photodynamic therapy, 2020-12, Vol.32, p.102064-102064, Article 102064

2020

Volltextzugriff (PDF)

Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker

Oncotarget, 2018-04, Vol.9 (32), p.22359-22367

2018

Volltextzugriff (PDF)

Development and evaluation of the MiCheck test for aggressive prostate cancer

Urologic oncology, 2020-08, Vol.38 (8), p.683.e11-683.e18

2020

Volltextzugriff (PDF)

RetroSPECT: Gallium-67 as a Long-Lived Imaging Agent for Theranostics

Asia oceania journal of nuclear medicine and biology, 2021-01, Vol.9 (1), p.1-8

2021

Volltextzugriff (PDF)

A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population—The MiCheck-01 prospective trial

Urologic oncology, 2020-08, Vol.38 (8), p.683.e1-683.e10

2020

Volltextzugriff (PDF)

A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma

Blood cancer journal (New York), 2019-07, Vol.9 (8), p.58-5, Article 58

2019

Volltextzugriff (PDF)

Safety and tolerability of Miltuximab® - a first in human study in patients with advanced solid cancers

Asia oceania journal of nuclear medicine and biology, 2021, Vol.9 (2), p.86-100

2021

Volltextzugriff (PDF)

EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer

Oncogene, 1997-09, Vol.15 (13), p.1617-1623

1997

Volltextzugriff (PDF)

Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt

Journal of cell science, 2004-08, Vol.117 (Pt 18), p.4157-4168

2004

Volltextzugriff (PDF)

1 – 25 von 771

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(567)
Mit Volltextzugriff
(610)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(769)

Erscheinungsjahr

n.n

Thema

Science & Technology
(472)
Life Sciences & Biomedicine
(329)
Humans
(236)
Female
(157)
Male
(138)
Middle Aged
(90)
Adult
(80)
Technology
(79)
Biological And Medical Sciences
(74)
Engineering
(65)
Engineering, Electrical & Electronic
(62)
Aged
(60)
Physical Sciences
(58)
Medical Sciences
(55)
Telecommunications
(55)
General & Internal Medicine
(52)
Animals
(50)
Optimization
(47)
Science & Technology - Other Topics
(44)
Adolescent
(41)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Science
(24)
Botanical Gazette
(17)
The Lancet
(16)
The American Naturalist
(13)
Colorectal Disease
(12)
Annals Of Botany
(11)
Optics Express
(10)
Plos One
(10)
The New England Journal Of Medicine
(10)
Bulletin Of The Torrey Botanical Club
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment

Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer

A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells

Glypican‐1 as a target for fluorescence molecular imaging of bladder cancer

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target

Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)

Enabling Sensitive Phenotypic Profiling of Cancer-Derived Small Extracellular Vesicles Using Surface-Enhanced Raman Spectroscopy Nanotags

The Role of Glypican-1 in the Tumour Microenvironment

Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican‑1 Targeting Immuno-PET Agents in Glioblastoma

PI3-kinase-dependent activation of apoptotic machinery occurs on commitment of epidermal keratinocytes to terminal differentiation

Pharmacokinetics and Biodistribution of 89 Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma

Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study

Upconversion nanoparticle‐assisted single‐molecule assay for detecting circulating antigens of aggressive prostate cancer

Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer

Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab ® -IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery

Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization

The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors

Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker

Development and evaluation of the MiCheck test for aggressive prostate cancer

RetroSPECT: Gallium-67 as a Long-Lived Imaging Agent for Theranostics

A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population—The MiCheck-01 prospective trial

A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma

Safety and tolerability of Miltuximab® - a first in human study in patients with advanced solid cancers

EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer

Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt

Suchergebnisse filtern